Screener
Shattuck Labs, Inc. STTK Business Segments — Net Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Shattuck Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 6:57 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-055483
| Revenue | Three Months Ended June 30, 2026 / $ | Three Months Ended June 30, 2026 / — | Three Months Ended June 30, 2025 / $ | Three Months Ended June 30, 2025 / — | Six Months Ended June 30, 2026 / $ | Six Months Ended June 30, 2026 / — | Six Months Ended June 30, 2025 / $ | Six Months Ended June 30, 2025 / — |
|---|---|---|---|---|---|---|---|---|
| Interest income | 1,029 | 804 | 1,832 | 1,416 | ||||
| Other expense | (26) | (230) | (52) | (155) | ||||
| Total other income | 1,003 | 574 | 1,780 | 1,261 | ||||
| Net loss | $ | $(15,152) | $ | $(12,458) | $ | $(29,919) | $ | $(26,160) |
| Unrealized (loss) gain on investments | (63) | 1 | (69) | (1) | ||||
| Comprehensive loss | $ | $(15,215) | $ | $(12,457) | $ | $(29,988) | $ | $(26,161) |
| Net loss per share – basic and diluted | $ | $(0.12) | $ | $(0.24) | $ | $(0.25) | $ | $(0.51) |
| Weighted-average shares outstanding – basic and diluted | 129,779,297 | 51,002,247 | 121,675,471 | 50,984,031 |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is Shattuck Labs, Inc.'s business segments — net loss?
- Shattuck Labs, Inc. (STTK) reported business segments — net loss of -$15.15M in Q2 2026.
- How has Shattuck Labs, Inc.'s business segments — net loss changed year-over-year?
- Shattuck Labs, Inc.'s business segments — net loss decreased by 21.6% year-over-year, from -$12.46M to -$15.15M.
- What is the long-term trend for Shattuck Labs, Inc.'s business segments — net loss?
- Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s business segments — net loss has grown at a -25.2% compound annual growth rate (CAGR), from -$87.3M to -$48.81M.
- What does business segments — net loss mean?
- This metric measures the bottom-line financial performance of the business segment after accounting for all operating expenses, research costs, and non-operating income. For a clinical-stage biotechnology company, it reflects the net capital burn required to advance the pipeline toward commercialization. It is a primary indicator of the segment's current reliance on external financing or cash reserves.
Ask your AI about Shattuck Labs, Inc.'s business segments — net loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude